The largest database of trusted experimental protocols

11 protocols using dmem f 12 glutamax media

1

Glioblastoma cell line characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
LN18, LN229, T98G (T98), U87-MG (U87) and U251 cell lines were purchased from the ATCC, USA, and cultured in DMEM medium (Dulbecco’s modified Eagle medium, Thermo Fisher Scientific, USA). Primary glioblastoma cell lines (WG4 and WG9) were derived as described [43 (link)] and cultured in DMEM/F12 GlutaMAX media (Thermo Fisher Scientific, USA). Normal human astrocytes (NHA, Lonza) were cultured in medium containing ABMTM Basal Medium (CC-3187) and AGMTM SingleQuotsTM Supplements (CC-4123) from Lonza.. All culture media were supplemented with 10% FBS (Gibco, USA), antibiotics (100 U/mL penicillin, 100 µg/mL streptomycin) and cultured in a humidified atmosphere of CO2/air (5%/95%) at 37 °C. Cells were treated with Temozolomide (Sigma, USA) alone or with combination with: Olaparib, 3-aminobenzamide, Rucaparib, Tioguanine or Etoposide. Aforementioned compounds were dissolved in DMSO. Irradiation of UV-C light was used with 30 J/m2 dose. For reagent specifications and catalogue numbers see the Supplementary Table S1.
+ Open protocol
+ Expand
2

Endothelial Differentiation from Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs were differentiated into CD31 + endothelial cells40 (link). For endothelial differentiation, iPSCs were dissociated into single cells and seeded onto Matrigel-coated plates at a density of 1 × 105 cells/cm2 in TeSR-E8 media supplemented with 10 μM Y − 27632. After 24 h, referred to as day 0, media was replaced with DMEM/F12 GlutaMAX media (Thermo Fisher Scientific) containing N-2 supplement (Thermo Fisher Scientific), B27 supplement, 8 mM CHIR99021 and 25 ng/mL BMP4 (STEMCELL Technologies) for 3 days. Media was then replaced with StemPro-34 SFM complete media (Thermo Fisher Scientific) supplemented with 200 ng/mL VEGF-165 (Peprotech) and 2 µM forskolin (Sigma-Aldrich) for 3 days. At day 6, hiPSC-derived endothelial cells were dissociated into single cells, resuspended in fluorescence-activated cell sorting (FACS) buffer (0.5% (w/v) BSA, 2 mM EDTA in DPBS) and incubated with conjugated FITC Mouse Anti-Human CD31 (1:10 dilution, #555445, clone WM59, BD Pharmingen, lot#8212882) for 30 mins. Stained cells were resuspended in FACS buffer, passed through a 40 µm mesh, and sorted using a BD FACS Aria III (Supplementary Fig. 34). An unstained cell sample was used as a negative control for gating. CD31 positive cells expanded on human fibronectin (Merck) coated plates and cultured in EGM2-MV media (Lonza) supplemented with 50 ng/mL VEGF-165.
+ Open protocol
+ Expand
3

Cultivation of Mouse Embryonic Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse embryonic fibroblasts obtained from (Cyagen, Suzhou, China). Cells were cultured in DMEM/F12 + GlutaMAX media (Gibco, Waltham, MA, United States) plus 10% fetal bovine serum (Excell, St. Louis, MO, United States), 100 U/mL streptomycin/penicillin (Gibco, Waltham, MA, United States), 1% 100 × NEAA (Sigma, St. Louis, MO, United States) at 37°C in a 5% CO2 cell incubator.
+ Open protocol
+ Expand
4

Standardized primary myoblast culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human primary myoblast cell lines were originating from the University of Rochester bio repository (http://www.urmc.rochester.edu/fields-center/). Muscle samples were obtained after subjects were consented under a protocol approved by the institutional review board at the University of Rochester. Myoblasts were cultured in DMEM/F-10 media (#31550, Gibco/Life Technologies, Bleiswijk, The Netherlands) supplemented with 20% heat inactivated fetal bovine serum (FBS #10270, Gibco/Life Technologies), 1% penicillin/streptomycin (#15140, Gibco/Life Technologies) and 10ng/ml rhFGF (#G5071, Promega, Leiden, The Netherlands) and 1μM dexamethasone (#D2915, Sigma-Aldrich, Zwijndrecht, The Netherlands) was added to the medium. Myoblasts were fused at 80% confluency by culturing them in DMEM/F-12 Glutamax media (#31331, Gibco/Life Technologies) containing 1% penicillin and streptomycin and 2% KnockOut serum replacement formulation (#10828, Gibco/Life Technologies) for 36 h. Human control fibroblast cell lines were maintained in DMEM/F-12, supplemented with 20% FBS, 1% penicillin and streptomycin, 10 mM HEPES (#15630#, Gibco/Life Technologies) and 1mM sodium pyruvate (##11360, Gibco/Life Technologies). Used cell lines, D4Z4 allele information, and experimental use are listed in Table S1.
+ Open protocol
+ Expand
5

Culturing ARPE-19 Retinal Pigment Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ARPE19 cells (American Type Culture Collection, Manassas, VA) were thawed at P23 from −80°C and were initially grown in a T25cm2 flask in DMEM/F12 + GlutaMAX media (Gibco Life Technologies, Carlsbad, CA) containing 10% Fetal bovine serum (FBS; Gibco Life Technologies, Carlsbad, CA) and 1% Antibiotic-Antimycotic (Gibco Life Technologies, Carlsbad, CA). Upon reaching approximately 90% confluency, ARPE19 cells were passaged using TrypLE (Gibco Life Technologies, Carlsbad, CA) and seeded at a 1:5 ratio. After the initial passage, ARPE19 cells (P24-P30) were cultured in T75cm2 flasks with DMEM/F12 + GlutaMAX media containing 10% FBS and 1% Anti-Anti and were passaged at 95% confluency.
+ Open protocol
+ Expand
6

Expansion and Bioprinting of ADSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADSCs from a single donor were isolated and expanded as previously described [113 (link)] with approval from the UTS Human Research Ethics Committee (Ethics number 2013000437). Written informed consent was acquired for donor lipoaspirate release for research purposes only. After isolation, and prior to experiments, the cells were maintained in DMEM/F12+Glutamax media (Gibco, Life Technologies, Carlsbad, CA, USA) with 10% heat inactivated FBS (Gibco, Life Technologies, Carlsbad, CA, USA) and incubated at 37 °C at 5% CO2. Cells used for these experiments were between passage ten and twelve.
At passage 10–12, cells were lifted from the tissue culture flasks using TrypLE express (12604 Gibco, Life Technologies, Roskilde, Denmark) and either re-plated into 96-well plates (2D) or prepared for bioprinting (3D) following manufacturer’s instructions.
Once the cells were re-plated in 2D or bioprinted, they were maintained in similar conditions as above with the addition of 1% antibiotics/antimycotics (ABAM, Gibco life technologies, Carlsbad, CA, USA) to the media; media was changed every 84 h using the same maintenance media and incubated at 37 °C at 5% CO2.
+ Open protocol
+ Expand
7

Culturing Dissociated Mouse Dorsal Root Ganglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dorsal root ganglia (DRG) were extracted aseptically from 4-week old male ICR (CD-1) mice (Harlan/Envigo) and placed in Hank’s Buffered Salt Solution (HBSS, Invitrogen) on ice. The ganglia were dissociated enzymatically at 37 C; first with collagenase A (1 mg/ml, Roche) for 25 min, then collagenase D (1 mg/ml, Roche) that included papain (30 ug/ml, Roche) for 20 min. Afterwards, a trypsin inhibitor (1 mg/ml, Roche) that contained bovine serum albumin (BSA, Fisher, 1 mg/ml) was used to homogenize the ganglia. The tissue was then filtered through 70 μm nylon filters (Falcon) and re-suspended in DMEM F-12 GlutaMax media (Invitrogen) that contained 10% fetal bovine serum (FBS, Hyclone) and 1x penicillin/streptomycin. The media also contained nerve growth factor (NGF, 10 ng/ml, Millipore) and cytosine arabinoside (Ara-C, 2.4ug/ml, Sigma). Neurons were cultured for seven days on 12 mm glass coverslips (#1 thickness, Chemglass) in a 24-well tissue culture plate (Falcon) at 37 C with 95% air and 5% CO2. On day 4, Ara-C was removed from the media and excluded for the remaining 3 days. On the day of the experiment, drugs were diluted into DMEM F-12 GlutaMax media and added directly into the neurons without any wash.
+ Open protocol
+ Expand
8

Extraction and Culture of Murine Dorsal Root Ganglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dorsal root ganglia (DRG) were extracted aseptically from 4-week old male ICR (CD-I) mice (Harlan/Envigo) and placed in Hank’s Buffered Salt Solution (HBSS, Invitrogen) on ice. The ganglia were dissociated enzymatically at 37 C; first with collagenase A (1 mg/ml, Roche) for 25 min, then collagenase D (1 mg/ml, Roche) that included papain (30ug/ml, Roche) for 20 min. Afterwards, a trypsin inhibitor (1 mg/ml, Roche) that contained bovine serum albumin (BSA, Fisher, 1 mg/ml) was used to homogenize the ganglia. The tissue was then filtered through 70 μm nylon filters (Falcon) and re-suspended in DMEM F-12 GlutaMax media (Invitrogen) that contained 10% fetal bovine serum (FBS, Hyclone) and 1× penicillin/streptomycin. The media also contained nerve growth factor (NGF, 10 ng/ml, Millipore) and cytosine arabinoside (Ara-C, 2.4ug/ml, Sigma). Neurons were cultured for seven days on 12 mm glass coverslips (#1 thickness, Chemglass) in a 24-well tissue culture plate (Falcon) at 37 C with 95% air and 5% CO2. On day 4, Ara-C was removed from the media and excluded for the remaining 3 days. On the day of the experiment, drugs were diluted into DMEM F-12 GlutaMax media and added directly into the neurons without any wash.
+ Open protocol
+ Expand
9

Nodose/Jugular Ganglia Culture and CGRP ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Our protocol was based on previous literature (Gavini et al., 2018 (link)). In particular, we chose to culture ganglia for 5–7 d to give the samples time to rebound from the injury caused by the acute dissection. Male mice (five to eight weeks) were deeply anesthetized with isoflurane before being decapitated and the nodose/jugular ganglia were quickly removed and stored in chilled HBSS (Invitrogen) on ice. The isolated ganglia were placed on a 30 mm, 0.4 μm pore size, hydrophilic Millicell culture insert (Millipore Sigma; catalog #PICM03050) and maintained on the insert in DMEM F-12 GlutaMax media (Invitrogen) supplemented with 20% heat-inactivated horse serum (Invitrogen, Life Technologies), and 1× penicillin streptomycin (Invitrogen). Cultures were maintained for 5–7 d with media changes every other day. After an overnight incubation in low serum (2.0%), cultures were stimulated with 500 ng/ml LPS or vehicle for 24 h before supernatant was collected. Supernatants were centrifuged to remove debris and loaded to a CGRP ELISA kit (Cayman Chemical; catalog #589001) and the protocol ran according to manufacturer’s instructions.
+ Open protocol
+ Expand
10

Maintenance of Engineered Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
All CHO cell lines were maintained in Dulbecco’s modified Eagle’s medium (DMEM)/F-12 media (Invitrogen) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and either geneticin (500 μg/ml; CHO-hKOR cells) or puromycin (5 μg/ml; CHO-hKOR-hGIRK and CHO-hKOR-hRGS cells). WT and βarr1/2-KO MEF-hKOR or mKOR cells were maintained in DMEM (Invitrogen) supplemented with 10% FBS, 1% penicillin/streptomycin, and puromycin (5 μg/ml). U2OS-hKOR cells (DiscoveRx) and U2OS-βarr2-GFP-mKOR cells were maintained in MEM (Invitrogen) supplemented with 10% FBS, 1% penicillin/streptomycin, geneticin (500 μg/ml), and hygromycin (250 μg/ml). SH-SY5Y-hKOR and parental SH-SY5Y cells were maintained in DMEM/F12 GlutaMax media (Invitrogen) supplemented with 10% FBS and 1% penicillin/streptomycin with or without puromycin (0.5 μg/ml). All cells were grown at 37°C under 5% CO2 and 95% humidity.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!